| Dr Ornela Dervishaj Kutzke, MD | |
|
5530 Wisconsin Ave Ste 711, Chevy Chase, MD 20815-4401 | |
| (917) 704-0465 | |
| Not Available |
| Full Name | Dr Ornela Dervishaj Kutzke |
|---|---|
| Gender | Female |
| Speciality | Plastic Surgery |
| Location | 5530 Wisconsin Ave Ste 711, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932597416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | MD467781 (Pennsylvania) | Primary |
| Entity Name | Affiliates In Plastic Surgery, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164848529 PECOS PAC ID: 2365664117 Enrollment ID: O20141111000271 |
News Archive
The White House has decided to allow an extra 24 hours for people to sign up for insurance on HealthCare.gov, through the end of the day Tuesday, to receive coverage beginning on Jan. 1, according to a senior official familiar with the change. The official deadline for getting insurance remains 11:59 p.m. on Monday. But because of record traffic on the website Monday morning, officials wanted to reassure the public -; and themselves -; that people who sought coverage in good faith would be covered (Shear, 12/23).
Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim) studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
"IDPs" is now a widely used acronym that stands for "intrinsically disordered proteins." It is the term generally used by the scientific community to refer to a wide variety of proteins that do not have a stable 3D structure and are instead characterized by a high extent of local mobility, disorder and many conformers that are accessible at room temperature.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
› Verified 6 days ago
| Entity Name | Dr. Ornela Kutzke Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740976992 PECOS PAC ID: 1153780416 Enrollment ID: O20230705000437 |
News Archive
The White House has decided to allow an extra 24 hours for people to sign up for insurance on HealthCare.gov, through the end of the day Tuesday, to receive coverage beginning on Jan. 1, according to a senior official familiar with the change. The official deadline for getting insurance remains 11:59 p.m. on Monday. But because of record traffic on the website Monday morning, officials wanted to reassure the public -; and themselves -; that people who sought coverage in good faith would be covered (Shear, 12/23).
Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim) studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
"IDPs" is now a widely used acronym that stands for "intrinsically disordered proteins." It is the term generally used by the scientific community to refer to a wide variety of proteins that do not have a stable 3D structure and are instead characterized by a high extent of local mobility, disorder and many conformers that are accessible at room temperature.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ornela Dervishaj Kutzke, MD 5530 Wisconsin Ave Ste 711, Chevy Chase, MD 20815-4401 Ph: (917) 704-0465 | Dr Ornela Dervishaj Kutzke, MD 5530 Wisconsin Ave Ste 711, Chevy Chase, MD 20815-4401 Ph: (917) 704-0465 |
News Archive
The White House has decided to allow an extra 24 hours for people to sign up for insurance on HealthCare.gov, through the end of the day Tuesday, to receive coverage beginning on Jan. 1, according to a senior official familiar with the change. The official deadline for getting insurance remains 11:59 p.m. on Monday. But because of record traffic on the website Monday morning, officials wanted to reassure the public -; and themselves -; that people who sought coverage in good faith would be covered (Shear, 12/23).
Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim) studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
"IDPs" is now a widely used acronym that stands for "intrinsically disordered proteins." It is the term generally used by the scientific community to refer to a wide variety of proteins that do not have a stable 3D structure and are instead characterized by a high extent of local mobility, disorder and many conformers that are accessible at room temperature.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
› Verified 6 days ago
Dr. Eric Maiorino, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave Ste 818, Chevy Chase, MD 20815 Phone: 301-654-5666 Fax: 301-654-5552 | |
Navin Singh, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, Suite 1710, Chevy Chase, MD 20815 Phone: 301-654-2030 Fax: 240-396-5110 | |
Dr. Gordon Wesley Price, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5550 Friendship Blvd, Suite 130, Chevy Chase, MD 20815 Phone: 301-652-7700 Fax: 301-907-6590 | |
Christopher Coleman Brown, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave #1210, Chevy Chase, MD 20815 Phone: 301-215-5955 Fax: 301-215-5944 | |
Jules Feledy Jr., MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave, Suite 818, Chevy Chase, MD 20815 Phone: 301-654-5666 Fax: 301-654-5552 | |
Dr. Sheilah Ann Lynch, M.D Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 1111, Chevy Chase, MD 20815 Phone: 301-652-5933 | |
Dr. Samir S. Rao, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5550 Friendship Boulevard, Suite 130, Chevy Chase, MD 20815 Phone: 301-652-7700 Fax: 301-907-6590 |